Detalhe da pesquisa
1.
Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 22(3)2024 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479107
2.
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
BMC Cancer
; 16: 468, 2016 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412386
3.
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 31-2015. A 29-Year-Old Man with Thymoma, Diarrhea, and Weight Loss.
N Engl J Med
; 373(15): 1458-67, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26444733
4.
Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer.
Eur J Nucl Med Mol Imaging
; 40(6): 832-41, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400506
5.
Expert Consensus Document on Pulmonary Metastasectomy.
Ann Thorac Surg
; 107(2): 631-649, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476477
6.
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
J Clin Oncol
; 27(4): 591-8, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19075278
7.
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 4(11): 1389-96, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19701107